标题
Gene of the month: Interleukin 6 (IL-6)
作者
关键词
-
出版物
JOURNAL OF CLINICAL PATHOLOGY
Volume 67, Issue 11, Pages 932-937
出版商
BMJ
发表日期
2014-07-17
DOI
10.1136/jclinpath-2014-202493
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sirukumab, a human anti-interleukin-6 monoclonal antibody: a randomised, 2-part (proof-of-concept and dose-finding), phase II study in patients with active rheumatoid arthritis despite methotrexate therapy
- (2014) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Synergistic effect of anti and pro-inflammatory cytokine genes and their promoter polymorphism with ST-elevation of myocardial infarction
- (2014) Santanu Biswas et al. GENE
- -174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race
- (2014) S. Mandal et al. GENETICS AND MOLECULAR RESEARCH
- Genetic polymorphism of interleukin-6 influences susceptibility to HBV-related hepatocellular carcinoma in a male Chinese Han population
- (2014) Shengli Tang et al. HUMAN IMMUNOLOGY
- IL-6 Regulates Neutrophil Trafficking during Acute Inflammation via STAT3
- (2014) C. A. Fielding et al. JOURNAL OF IMMUNOLOGY
- Interleukin-6 gene polymorphism, chronic stress and atherosclerosis
- (2014) Nadja Chumaeva et al. JOURNAL OF PSYCHOSOMATIC RESEARCH
- Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
- (2014) Tomoyuki Imagawa et al. Modern Rheumatology
- Frequencies of interleukin-6, GST and progesterone receptor gene polymorphisms in postmenopausal women with low bone mineral density
- (2014) Katia Franco Moura et al. Sao Paulo Medical Journal
- Inflammation Amplifier, a New Paradigm in Cancer Biology
- (2013) T. Atsumi et al. CANCER RESEARCH
- Minocycline Targets the NF-κB Nexus through Suppression of TGF-β1-TAK1-IκB Signaling in Ovarian Cancer
- (2013) Parvin Ataie-Kachoie et al. MOLECULAR CANCER RESEARCH
- Impact of Interleukin-6 –174 G>C Gene Promoter Polymorphism on Neuroblastoma
- (2013) Francesca Totaro et al. PLoS One
- Interleukin-6 signaling pathway in targeted therapy for cancer
- (2012) Yuqi Guo et al. CANCER TREATMENT REVIEWS
- Molecular Link Mechanisms between Inflammation and Cancer
- (2012) D. B. Vendramini-Costa et al. CURRENT PHARMACEUTICAL DESIGN
- Plasticity and cross-talk of Interleukin 6-type cytokines
- (2012) Christoph Garbers et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Inhibition of the IL-6 signaling pathway: A strategy to combat chronic inflammatory diseases and cancer
- (2012) Parvin Ataie-Kachoie et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Minocycline inhibits growth of epithelial ovarian cancer
- (2012) Mohammad H. Pourgholami et al. GYNECOLOGIC ONCOLOGY
- Minocycline inhibits malignant ascites of ovarian cancer through targeting multiple signaling pathways
- (2012) Mohammad Hossein Pourgholami et al. GYNECOLOGIC ONCOLOGY
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- Aspirin use and risk for lung cancer: a meta-analysis
- (2011) S.-W. Oh et al. ANNALS OF ONCOLOGY
- Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry
- (2011) H. C. Leffers et al. ANNALS OF THE RHEUMATIC DISEASES
- Therapeutic Targeting of the Interleukin-6 Receptor
- (2011) Toshio Tanaka et al. Annual Review of Pharmacology and Toxicology
- Interleukin-6, a mental cytokine
- (2011) Anneleen Spooren et al. BRAIN RESEARCH REVIEWS
- Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma
- (2011) Sally A. Hunsucker et al. BRITISH JOURNAL OF HAEMATOLOGY
- Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy
- (2011) Eric Tartour et al. CANCER AND METASTASIS REVIEWS
- Aspirin, Nonsteroidal Anti-inflammatory Drugs, Acetaminophen, and Pancreatic Cancer Risk: a Clinic-Based Case-Control Study
- (2011) X.-L. Tan et al. Cancer Prevention Research
- Celecoxib Inhibits Interleukin-6/Interleukin-6 Receptor-Induced JAK2/STAT3 Phosphorylation in Human Hepatocellular Carcinoma Cells
- (2011) Y. Liu et al. Cancer Prevention Research
- Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
- (2011) Jermaine Coward et al. CLINICAL CANCER RESEARCH
- IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
- (2011) Markus F. Neurath et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
- (2011) K. Fizazi et al. EUROPEAN JOURNAL OF CANCER
- A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer
- (2011) Trevor J Bayliss et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Long-Term Use of Nonsteroidal Anti-inflammatory Drugs Decreases the Risk of Cutaneous Melanoma: Results of a United States Case–Control Study
- (2011) Clara Curiel-Lewandrowski et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma
- (2011) Satoru Shinriki et al. JOURNAL OF PATHOLOGY
- Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy
- (2011) L S Steelman et al. LEUKEMIA
- JAK1 Activates STAT3 Activity in Non-Small-Cell Lung Cancer Cells and IL-6 Neutralizing Antibodies Can Suppress JAK1-STAT3 Signaling
- (2011) L. Song et al. MOLECULAR CANCER THERAPEUTICS
- Silencing STAT3 may inhibit cell growth through regulating signaling pathway, telomerase, cell cycle, apoptosis and angiogenesis in hepatocellular carcinoma: potential uses for gene therapy
- (2011) X. WANG et al. NEOPLASMA
- Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: A mechanistic link between local and systemic inflammation
- (2011) Ying Gu et al. PHARMACOLOGICAL RESEARCH
- Combinatorial Effect of Non-Steroidal Anti-inflammatory Drugs and NF-κB Inhibitors in Ovarian Cancer Therapy
- (2011) Luiz F. Zerbini et al. PLoS One
- The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study
- (2011) Jayaprakash Karkera et al. PROSTATE
- Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study
- (2011) T. Takeuchi et al. RHEUMATOLOGY
- Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)
- (2010) G. R. Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study
- (2010) Gabor G. Illei et al. ARTHRITIS AND RHEUMATISM
- Future drug developments in multiple myeloma: an overview of novel lenalidomide-based combination therapies
- (2010) Gareth Morgan BLOOD REVIEWS
- Activation of c-Jun N-terminal kinase is essential for mitochondrial membrane potential change and apoptosis induced by doxycycline in melanoma cells
- (2010) Jiunn-Min Shieh et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacokinetic and Pharmacodynamic Modeling of an Anti-Interleukin-6 Chimeric Monoclonal Antibody (Siltuximab) in Patients with Metastatic Renal Cell Carcinoma
- (2010) T. Puchalski et al. CLINICAL CANCER RESEARCH
- Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer
- (2010) T. B. Dorff et al. CLINICAL CANCER RESEARCH
- Signal transduction pathways and transcriptional regulation in Th17 cell differentiation
- (2010) Kiyoshi Hirahara et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Interleukin-6 in bone metastasis and cancer progression
- (2010) Tasnim Ara et al. EUROPEAN JOURNAL OF CANCER
- Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer
- (2010) Wenjing Tian et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer
- (2010) Athena Chalaris et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Naphtho[1,2-b]furan-4,5-dione induces apoptosis of oral squamous cell carcinoma: Involvement of EGF receptor/PI3K/Akt signaling pathway
- (2010) Ching-Ming Chien et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: A meta-analysis
- (2010) Salaheddin M. Mahmud et al. INTERNATIONAL JOURNAL OF CANCER
- Siltuximab, a Novel Anti–Interleukin-6 Monoclonal Antibody, for Castleman's Disease
- (2010) Frits van Rhee et al. JOURNAL OF CLINICAL ONCOLOGY
- The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
- (2010) Y. Shima et al. RHEUMATOLOGY
- Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis
- (2009) C C Abnet et al. BRITISH JOURNAL OF CANCER
- Targeted inhibition of interleukin-6 with CNTO 328 sensitizes pre-clinical models of multiple myeloma to dexamethasone-mediated cell death
- (2009) Peter M. Voorhees et al. BRITISH JOURNAL OF HAEMATOLOGY
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
- (2009) Julia Bollrath et al. CANCER CELL
- Recent developments and complexities in neutrophil transmigration
- (2009) Abigail Woodfin et al. CURRENT OPINION IN HEMATOLOGY
- Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells
- (2009) Frédéric R Santer et al. ENDOCRINE-RELATED CANCER
- Antitumor effect of humanized anti–interleukin-6 receptor antibody (tocilizumab) on glioma cell proliferation
- (2009) Mareina Kudo et al. JOURNAL OF NEUROSURGERY
- Successful treatment of a patient with takayasu arteritis using a humanized anti-interleukin-6 receptor antibody
- (2008) Norihiro Nishimoto et al. ARTHRITIS AND RHEUMATISM
- Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?
- (2008) Sergei Grivennikov et al. CANCER CELL
- The Growth-Inhibitory Effects of Dexamethasone on Renal Cell CarcinomaIn VivoandIn Vitro
- (2008) Yasuyuki Arai et al. CANCER INVESTIGATION
- Cytokine and cytokine receptor gene polymorphisms and their functionality
- (2008) Andrew J.P. Smith et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Systematic review of the association between circulating interleukin-6 (IL-6) and cancer
- (2008) Katriina Heikkilä et al. EUROPEAN JOURNAL OF CANCER
- Activation of NF-κB by extracellular S100A4: Analysis of signal transduction mechanisms and identification of target genes
- (2008) Kjetil Boye et al. INTERNATIONAL JOURNAL OF CANCER
- Stat3 mediates myeloid cell–dependent tumor angiogenesis in mice
- (2008) Maciej Kujawski et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
- (2008) Shumpei Yokota et al. LANCET
- IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis
- (2008) Satoshi Serada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation